NIH-funded research R21 grant

Investigating how Hedgehog signaling controls lung development and disease

Official title: Hedgehog Signaling as a regulator of progenitor differentiation for organ maintenance and disease

Funded at University of Chicago · NIH-11045334 · Data updated 2026-11-12

This study is looking at how a specific signaling pathway in our cells affects the way lung cells develop, which could help us understand and find new treatments for lung diseases like COPD and pulmonary fibrosis.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startFebruary 1, 2025
Project endNovember 30, 2026
Funding year2025
Award (this year)$123,000
NIH project number1R21HL177730-01
Project IDNIH-11045334 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis.

Less likely to help

Patients with lung diseases not related to Hedgehog signaling or those under 21 years old may not benefit from this research.

What this research studies

This research explores the role of the Hedgehog (Hh) signaling pathway in regulating the timing of lung cell differentiation during development and its potential implications for lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF). By analyzing existing single-cell data from both mouse and human lungs, the project aims to understand how changes in Hh signaling can affect lung cell populations. The research employs a computational approach to track and characterize Hh-receiving cells, providing insights into their behavior in healthy and diseased states. Ultimately, this work seeks to identify specific genes influenced by Hh signaling that could be targeted for therapeutic interventions.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic targets for treating lung diseases like COPD and IPF.

How similar studies have gone: Previous research has shown promising results in understanding the role of signaling pathways in organ development, suggesting potential for success in this area.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Yang, Xinan Holly — University of Chicago
  • Study coordinator: Yang, Xinan Holly

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.